{"id":"W2087469963","doi":"10.1186/1471-2474-9-118","title":"A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients","year":2008,"lang":"en","type":"article","venue":"BMC Musculoskeletal Disorders","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novartis Pharma","keywords":"Medicine; Tolerability; Rofecoxib; Adverse effect; Internal medicine; Diclofenac; Blood pressure; Peripheral edema; Anesthesia; Incidence (geometry); Cyclooxygenase","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001054558,0.0005277338,0.00180987,0.0003908815,0.0001875898,0.00001391824,0.0001797154,0.0003255247,0.0001132449],"category_scores_gemma":[0.0005342298,0.0004492898,0.0006977469,0.0004194057,0.0003624916,0.0002801478,0.0001394108,0.0006036268,0.00003300698],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000839531,"about_ca_system_score_gemma":0.0002310507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004840713,"about_ca_topic_score_gemma":0.004849123,"domain_scores_codex":[0.9954629,0.000640269,0.00170648,0.0008000074,0.0007345635,0.000655798],"domain_scores_gemma":[0.9974623,0.0008769008,0.0004889673,0.0005619786,0.0001888724,0.0004209371],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3311891,0.007524672,0.6466198,0.0003696709,0.0002133659,0.0000422651,0.0014754,0.00002268945,0.00002397108,0.00001103333,0.00004116838,0.01246689],"study_design_scores_gemma":[0.5314803,0.0032268,0.4634611,0.0001073927,0.0002173871,0.000005020029,0.0009025926,0.0001763052,0.00001935233,0.00000347712,0.0001227664,0.0002775154],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860958,0.0004194916,0.00002371361,0.00004106203,0.0005798133,0.01137677,0.00001084367,0.00006381807,0.001388683],"genre_scores_gemma":[0.9982619,0.0005528713,0.000104222,0.00004663383,0.0001594742,0.0005879196,0.00006484739,0.0000706601,0.0001514892],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2002912,"threshold_uncertainty_score":0.9997959,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02672852170835261,"score_gpt":0.310400124914085,"score_spread":0.2836716032057324,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}